Skip to main content
logo
Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
71.30
+0.36 (0.50%)
Jul 30, 2026, 10:16 AM EDT - Market open

Utah Medical Products Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
227178205306365365
Market Cap Growth
19.31%-13.03%-32.93%-16.18%-0.21%19.00%
Enterprise Value
138.4692.76122.31213.11289.99304.9
Last Close Price
71.3055.9661.4784.22100.53100.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.6116.0815.5218.4322.2424.75
Forward PE
-17.8017.8017.8017.8017.80
PEG Ratio
-1.191.191.191.191.19
PS Ratio
6.254.635.016.096.987.45
PB Ratio
1.851.491.752.383.193.41
P/TBV Ratio
-1.742.132.794.054.86
P/FCF Ratio
17.3412.4514.0414.1217.9317.70
P/OCF Ratio
16.9312.1413.8213.7217.2517.24

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.832.412.994.245.556.22
EV/EBITDA Ratio
13.496.447.449.2110.7911.65
EV/EBIT Ratio
13.498.149.0012.7014.6516.15
EV/FCF Ratio
10.636.488.389.8514.2614.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.000.000.000.00
Debt / EBITDA Ratio
0.020.020.020.010.010.02
Debt / FCF Ratio
-0.020.020.010.020.02
Net Debt / Equity Ratio
--0.72-0.70-0.72-0.65-0.56
Net Debt / EBITDA Ratio
-8.51-5.94-5.03-4.00-2.78-2.31
Net Debt / FCF Ratio
--5.97-5.66-4.28-3.67-2.93
Asset Turnover
0.290.310.320.390.440.43
Inventory Turnover
1.351.971.822.192.612.83
Quick Ratio
44.0134.3623.1820.4413.5217.65
Current Ratio
48.6237.6225.6422.5615.0919.53
Return on Equity (ROE)
8.92%9.54%11.29%13.72%14.88%14.09%
Return on Assets (ROA)
7.15%7.44%8.70%10.71%13.18%12.88%
Return on Invested Capital (ROIC)
-26.64%31.86%36.91%36.65%29.85%
Return on Capital Employed (ROCE)
8.47%9.55%10.90%13.49%17.22%17.18%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
4.64%6.22%6.44%5.43%4.50%4.04%
FCF Yield
5.77%8.03%7.12%7.08%5.58%5.65%
Dividend Yield
1.75%2.20%1.98%1.40%0.87%3.14%
Payout Ratio
37.77%35.29%30.70%25.74%19.20%77.53%
Buyback Yield / Dilution
4.75%7.51%3.68%0.16%0.46%0.33%
Total Shareholder Return
6.50%9.70%5.66%1.57%1.33%3.47%
SEC Filings: 10-K · 10-Q